Neoantigen Summit Europe, April 7-9 in Amsterdam

Jan 10, 2020

CEO Gerben Zondag will present Immunetune’s unique platform that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming Neoantigen Summit Europe, 7-9 April in Amsterdam.

Update March 12. Unfortunately, but fully understandably, the organizers decided to cancel this meeting in the best interest of all attendees. The Neoantigen Summit will be back in Boston, scheduled November 2020, I look forward to seeing you there.

kind regards,

Gerben

Immunetune joins the fight against Sars-CoV-2

Immunetune joins the fight against Sars-CoV-2

Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell...

read more